SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 29.92 CNY 0.17%
Market Cap: 12.9B CNY
Have any thoughts about
SonoScape Medical Corp?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
SonoScape Medical Corp

Wall Street analysts forecast SonoScape Medical Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SonoScape Medical Corp is 42.6 CNY with a low forecast of 38.03 CNY and a high forecast of 48.3 CNY.

Lowest Forecast
Wall Street Target
38.03 CNY
27% Upside
Average Forecast
Wall Street Target
42.6 CNY
42% Upside
Highest Forecast
Wall Street Target
48.3 CNY
61% Upside
Lowest
Price Target
38.03 CNY
27% Upside
Average
Price Target
42.6 CNY
42% Upside
Highest
Price Target
48.3 CNY
61% Upside
SonoScape Medical Corp Competitors:
Price Targets
PDEX
Pro-Dex Inc
11% Upside
IPD
ImpediMed Ltd
220% Upside
N
NXTMH
Nexstim Oyj
15% Upside
COH
Cochlear Ltd
12% Upside
PDEX
Pro-Dex Inc
11% Upside
IPD
ImpediMed Ltd
220% Upside
N
NXTMH
Nexstim Oyj
15% Upside
COH
Cochlear Ltd
12% Upside
L
300003
Lepu Medical Technology Beijing Co Ltd
20% Upside
LMAT
LeMaitre Vascular Inc
27% Upside
M
179290
MITech Co Ltd
77% Upside
7716
Nakanishi Inc
32% Upside

Revenue
Forecast

Revenue Estimate
SonoScape Medical Corp

For the last 8 years the compound annual growth rate for SonoScape Medical Corp's revenue is 15%. The projected CAGR for the next 4 years is 10%.

15%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
SonoScape Medical Corp

For the last 8 years the compound annual growth rate for SonoScape Medical Corp's operating income is 25%. The projected CAGR for the next 3 years is 8%.

25%
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
SonoScape Medical Corp

For the last 8 years the compound annual growth rate for SonoScape Medical Corp's net income is 20%. The projected CAGR for the next 3 years is 11%.

20%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SonoScape Medical Corp's stock price target?
Price Target
42.6 CNY

According to Wall Street analysts, the average 1-year price target for SonoScape Medical Corp is 42.6 CNY with a low forecast of 38.03 CNY and a high forecast of 48.3 CNY.

What is SonoScape Medical Corp's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for SonoScape Medical Corp's revenue is 15%. The projected CAGR for the next 4 years is 10%.

What is SonoScape Medical Corp's Operating Income forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for SonoScape Medical Corp's operating income is 25%. The projected CAGR for the next 3 years is 8%.

What is SonoScape Medical Corp's Net Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for SonoScape Medical Corp's net income is 20%. The projected CAGR for the next 3 years is 11%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.